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Background
Hemophagocytic lymphohistiocytosis (HLH) is a life-threa-
tening disease in which an exaggerated but ineffective
immune response leads to severe hyper inflammation. It
commonly affects infants from birth to 18 months of age,
but cases in older children and adults have also been
reported. Key players in HLH are activated lymphocytes
and histiocytes, they infiltrate all organs and secrete large
amounts of cytokines. Cardinal symptoms are prolonged
fever, hepatosplenomegaly, cytopenias and hemophagocy-
tosis [1]. The aim of this case presentation is to focus on
the unique presentations of HLH syndrome and to be
aware of unusual presentations, so that we could diagnose
early and treat it appropriately to ensure long term survival.
Case presentation
19 yr old young boy presented with high fever, rigors &
lethargy 5 weeks after been to Spain. Investigations
showed neutropenia, lymphopenia & abnormal LFT’s
(WCC 1.2, Neut 0.7, ALT 815, ESR 13, CRP<5). Septic
screen, HIV, hepatitis screen & Paul bunnel test were
negative.
Fever continued despite 9 days of Intravenous antibio-
tics. CT chest/abdo/pelvis revealed oedematous and thick-
ening of psoas, rectus and paraspinous muscle suggestive
of myositis. CK was raised at 7200, subsequent EMG and
muscle biopsy confirmed polymyositis.
Reviewed by Haematology team, started on granulocyte
colony stimulating factor. Bone marrow biopsy showed
increased number of megakaryocytes with evidence of
clustering, normocellular marrow with non specific
changes. He developed diffuse macular rash, diagnosis of
lupus/myositis overlap considered and had 3 doses of
pulse IV Methyl prednisolone, then switch to oral predni-
solone 60 mg.
He developed shortness of breath due to bilateral pleural
effusion leading to hypoxia requiring chest drain. Autoan-
tibody screen including Jo 1, Mi-2, Ku & Pl-7, Ds DNA,
anticardiolipin antibody were negative and complements
came back as normal. Ferritin was high at 10,000 and con-
tinued to have swinging fever, neutropenia and abnormal
LFT’s.
On review of clinical presentation and investigations
we suspected HLH syndrome and referred back to
Haematology. Repeat bone marrow biopsies confirmed
heamophagocytosis. He fulfilled criteria for diagnosis of
Haemophagocytic lymphohistiocytosis (HLH) and contin-
ued with high dose oral steroids & started on Cyclosporine
as steroid sparing agent. His blood counts and muscle
weakness improved gradually over next 3 months.
Discussion
Haemophagocytic syndrome can be primary due to
mutations in different genes or secondary in association
with infections, autoimmune or malignant disorders [2].
A series of adult patients with HLH and a variety of auto-
immune diseases including lupus erythematosus, rheu-
matoid arthritis, Still’s disease, polyarteritis nodosa,
mixed connective tissue disease, pulmonary sarcoidosis,
systemic sclerosis, and Sjogren’s syndrome have been
reported. However this is the first case reported of HLH
syndrome presenting as Polymyositis.
5 out of 9 following criteria should be present to diag-
nose HLH syndrome [3].
1. Fever
2. Splenomegaly
3. Cytopenias involving two or more cell lines
4. Hypertriglyceridemia or hypofibrinogenemia
5. Hemophagocytosis on bone marrow
6. Hepatitis
7. Low or absent natural killer activity
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8. Serum ferritin level > 500 micrograms/l
9. Soluble CD25 > 2400 U/ml
There are published observational data suggest that
the TNF inhibitor etanercept is potentially useful for
obtaining remission in children not responding to ster-
oids and cyclosporin A [4].
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